MetaCap

Grifols S.A. ADR Company Profile

NASDAQ: GRFSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

8.15-0.05 (-0.61%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Grifols S.A. at a glance

Grifols S.A. ADR (NASDAQ: GRFS) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Barcelona, NY, Spain. Grifols S.A. is led by Mr. Jose Ignacio Abia Buenache and employs about 25,000 people. At a market capitalization of $5.64 billion, it is considered a mid-cap company.

Its SEC Central Index Key (CIK) is 0001438569, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Grifols S.A. do?

Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.

Business description based on the company's public filings.

Company information

Legal name
Grifols S.A. ADR
Ticker
NASDAQ: GRFS
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Jose Ignacio Abia Buenache
Employees
25,000
Headquarters
Parque Empresarial Can Sant Joan, Barcelona, NY, Spain
Phone
34 935 71 22 00
SEC CIK
0001438569

Companies similar to Grifols S.A.

GRFS peer companies
CompanyPrice% ChgMarket capCompare
LGNDLigand Pharmaceuticals Incorporated286.85-0.03%$5.74Bvs GRFS
ARWRArrowhead Pharmaceuticals Inc.41.37-5.22%$5.85Bvs GRFS
SUPNSupernus Inc.28.61+0.92%$5.94Bvs GRFS
BLTEBelite Bio Inc ADR127.38-15.65%$5.17Bvs GRFS
MANEVeradermics Incorporated119.52-3.92%$5.04Bvs GRFS
MIRMMirum Pharmaceuticals Inc.96.13+0.65%$6.28Bvs GRFS
LQDALiquidia Corporation54.43-3.88%$4.90Bvs GRFS
ABVXAbivax SA ADR73.20-9.24%$6.41Bvs GRFS

Related